HGH Fragment - Livewell Pharmaceuticals

HGH Fragment 176-191 is a modified peptide consisting of the last 16 amino acids of native growth hormone’s 191 sequence. It does not bind GH receptors or increase IGF-1, thus lacks anabolic effects. However, it retains potential fat-burning properties and is used in the fitness community for lipolysis. Initially described in 1976, its development stopped in the early 1980s. Though structurally similar to AOD9604, it is a distinct compound. Clinical data is lacking, and it remains an unapproved research chemical with uncertain human efficacy.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about HGH Fragment by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.